Collaborating Across Borders: Building & Using Evidence to Enable Access
Thank you for attending ISPOR Europe 2022. Access to the virtual platform is available until 9 December 2022 which includes on demand viewing of ISPOR Europe 2022 content, posters, and networking. Slide presentations and handouts from the conference will be available (subject to speaker approval) within the virtual platform. Additionally, the final versions of slide presentations will also be available within the ISPOR Presentation Database as well as the ISPOR Europe 2022 Program page beginning 21 December.
Speakers
Health Economist, HTA economic evaluation and RWE applied to HTA | Ministry of Health
Associate Professor, Coordinator, Program Personalized and Precision Medicine | UMIT TIROL, Austria
Qualified Medical Doctor | University of Autonoma in Madrid, specialized in urology
Chair, ABH ISustainability working group, and vice-chairs the Commercial policy group | Boston Scientific
Chair of Digital Medicine and head of the Digital Medicine | University of Luxemburg
Director of Medical Technology - Commercial, Strategy and Policy Department for Health and Social Care (DHSC) | Guys & St Thomas' NHS Foundation Trust
Chairwoman of the Board | Health Policy Institute, Medical University of Gdańsk, Poland
Head of Market Access & Value Based Healthcare (VBHC) Lead Medication Delivery Systems (MDS) | BD Europe, Switzerland
Professor of Health Economics | Centre for Health Economics, University of York, York, UK
Chief Science Officer & Strategic Lead, Clinical Outcome Assessments | Clinical Outcomes Solutions, Folkestone, Kent, UK
Professor and Chair | UMIT TIROL-University for Health Sciences and Technology Hall in Tirol, Austria, and Harvard Chan School of Public Health Boston, USA
Professor of Health Economics & Director of the Centre for Health Policy | University of Melbourne, Melbourne, Victoria, Australia